288 related articles for article (PubMed ID: 15314233)
1. Discovery of an allosteric site in the caspases.
Hardy JA; Lam J; Nguyen JT; O'Brien T; Wells JA
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12461-6. PubMed ID: 15314233
[TBL] [Abstract][Full Text] [Related]
2. A common allosteric site and mechanism in caspases.
Scheer JM; Romanowski MJ; Wells JA
Proc Natl Acad Sci U S A; 2006 May; 103(20):7595-600. PubMed ID: 16682620
[TBL] [Abstract][Full Text] [Related]
3. A multipronged approach for compiling a global map of allosteric regulation in the apoptotic caspases.
Dagbay K; Eron SJ; Serrano BP; Velázquez-Delgado EM; Zhao Y; Lin D; Vaidya S; Hardy JA
Methods Enzymol; 2014; 544():215-49. PubMed ID: 24974292
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific tethered inhibitors for caspase-5.
Gao J; Wells JA
Chem Biol Drug Des; 2012 Feb; 79(2):209-15. PubMed ID: 22014003
[TBL] [Abstract][Full Text] [Related]
5. Tunable allosteric library of caspase-3 identifies coupling between conserved water molecules and conformational selection.
Maciag JJ; Mackenzie SH; Tucker MB; Schipper JL; Swartz P; Clark AC
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6080-E6088. PubMed ID: 27681633
[TBL] [Abstract][Full Text] [Related]
6. Tailoring small molecules for an allosteric site on procaspase-6.
Murray J; Giannetti AM; Steffek M; Gibbons P; Hearn BR; Cohen F; Tam C; Pozniak C; Bravo B; Lewcock J; Jaishankar P; Ly CQ; Zhao X; Tang Y; Chugha P; Arkin MR; Flygare J; Renslo AR
ChemMedChem; 2014 Jan; 9(1):73-7, 2. PubMed ID: 24259468
[TBL] [Abstract][Full Text] [Related]
7. Modulating caspase activity: beyond the active site.
Murray J; Renslo AR
Curr Opin Struct Biol; 2013 Dec; 23(6):812-9. PubMed ID: 24215810
[TBL] [Abstract][Full Text] [Related]
8. Conformational restrictions in the active site of unliganded human caspase-3.
Ni CZ; Li C; Wu JC; Spada AP; Ely KR
J Mol Recognit; 2003; 16(3):121-4. PubMed ID: 12833566
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway.
Schweizer A; Briand C; Grutter MG
J Biol Chem; 2003 Oct; 278(43):42441-7. PubMed ID: 12920126
[TBL] [Abstract][Full Text] [Related]
10. Allosteric disulfide bonds.
Schmidt B; Ho L; Hogg PJ
Biochemistry; 2006 Jun; 45(24):7429-33. PubMed ID: 16768438
[TBL] [Abstract][Full Text] [Related]
11. Modifying caspase-3 activity by altering allosteric networks.
Cade C; Swartz P; MacKenzie SH; Clark AC
Biochemistry; 2014 Dec; 53(48):7582-95. PubMed ID: 25343534
[TBL] [Abstract][Full Text] [Related]
12. The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.
Blanchard H; Kodandapani L; Mittl PR; Marco SD; Krebs JF; Wu JC; Tomaselli KJ; Grütter MG
Structure; 1999 Sep; 7(9):1125-33. PubMed ID: 10508784
[TBL] [Abstract][Full Text] [Related]
13. Dissecting an allosteric switch in caspase-7 using chemical and mutational probes.
Hardy JA; Wells JA
J Biol Chem; 2009 Sep; 284(38):26063-9. PubMed ID: 19581639
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of caspase-9 by stabilized peptides targeting the dimerization interface.
Huber KL; Ghosh S; Hardy JA
Biopolymers; 2012; 98(5):451-65. PubMed ID: 23203690
[TBL] [Abstract][Full Text] [Related]
15. How do mutations and allosteric inhibitors modulate caspase-7 activity? A molecular dynamics study.
Bingöl EN; Serçinoğlu O; Ozbek P
J Biomol Struct Dyn; 2019 Aug; 37(13):3456-3466. PubMed ID: 30175666
[TBL] [Abstract][Full Text] [Related]
16. Dimer formation drives the activation of the cell death protease caspase 9.
Renatus M; Stennicke HR; Scott FL; Liddington RC; Salvesen GS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14250-5. PubMed ID: 11734640
[TBL] [Abstract][Full Text] [Related]
17. Allosteric regulation of proteases.
Hauske P; Ottmann C; Meltzer M; Ehrmann M; Kaiser M
Chembiochem; 2008 Dec; 9(18):2920-8. PubMed ID: 19021141
[TBL] [Abstract][Full Text] [Related]
18. Caspase Allostery and Conformational Selection.
Clark AC
Chem Rev; 2016 Jun; 116(11):6666-706. PubMed ID: 26750439
[TBL] [Abstract][Full Text] [Related]
19. Insights into the evolution of allosteric properties. The NADH binding site of hexameric type II citrate synthases.
Maurus R; Nguyen NT; Stokell DJ; Ayed A; Hultin PG; Duckworth HW; Brayer GD
Biochemistry; 2003 May; 42(19):5555-65. PubMed ID: 12741811
[TBL] [Abstract][Full Text] [Related]
20. Structure-based combinatorial library design: discovery of non-peptidic inhibitors of caspases 3 and 8.
Head MS; Ryan MD; Lee D; Feng Y; Janson CA; Concha NO; Keller PM; deWolf WE
J Comput Aided Mol Des; 2001 Dec; 15(12):1105-17. PubMed ID: 12160093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
